hyperthyroidism and tirzepatide levothyroxine: guide to managing both medications safely Tirzepatide & Hyperthyroidism: Safe Weight
Description
& Sipos, J
Tirzepatide, by contrast, is a dual GLP-1 and GIP receptor agonist that reduces appetite, slows gastric emptying, and increases insulin sensitivity through central nervous system signaling
Available in oral form (Rybelsus)
Brands that provide transparent certificates of analysis (COAs) and independent testing results receive the highest ratings
Most patients remain on 5mg for 4-8 weeks before increasing further, depending on weight loss progress and tolerance
Instead of one large spike, you get two smaller ones
